Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HORWITZ

Showing results (661-670 of 831) with videos related to

Pageof 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108Paul M Barr, Hongli Li, Catherine Spier, et al.
Blood Cancer Journal|August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab eraGiulio Cassanello, Esther Drill, Annie Qiu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 31, 2003
Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosisAnnalisa Frattini, Alessandra Pangrazio, Lucia Susani, et al.
Blood Advances|January 26, 2021
Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissueErel Joffe, Yan Leyfman, Esther Drill, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
Stem Cells Translational Medicine|September 10, 2017
Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical TrialsAdam J Guess, Beth Daneault, Rongzhang Wang, et al.
American Journal of Hematology|November 12, 2019
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomasFrancine M Foss, Steven M Horwitz, Monica Civallero, et al.
Nature Biotechnology|July 15, 2025
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainableSadik H Kassim, Fyodor Urnov, Kiran Musunuru, et al.
Haematologica|December 22, 2018
Mogamulizumab <i>versus</i> investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphomaAdrienne A Phillips, Paul A Fields, Olivier Hermine, et al.
Blood|May 28, 2015
Hematopoietic stem cell transplantation for infantile osteopetrosisPaul J Orchard, Anders L Fasth, Jennifer Le Rademacher, et al.
Pageof 84

Showing results (661-670 of 831) with videos related to

Sort By:
Pageof 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108Paul M Barr, Hongli Li, Catherine Spier, et al.
Blood Cancer Journal|August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab eraGiulio Cassanello, Esther Drill, Annie Qiu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 31, 2003
Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosisAnnalisa Frattini, Alessandra Pangrazio, Lucia Susani, et al.
Blood Advances|January 26, 2021
Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissueErel Joffe, Yan Leyfman, Esther Drill, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
Stem Cells Translational Medicine|September 10, 2017
Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical TrialsAdam J Guess, Beth Daneault, Rongzhang Wang, et al.
American Journal of Hematology|November 12, 2019
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomasFrancine M Foss, Steven M Horwitz, Monica Civallero, et al.
Nature Biotechnology|July 15, 2025
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainableSadik H Kassim, Fyodor Urnov, Kiran Musunuru, et al.
Haematologica|December 22, 2018
Mogamulizumab <i>versus</i> investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphomaAdrienne A Phillips, Paul A Fields, Olivier Hermine, et al.
Blood|May 28, 2015
Hematopoietic stem cell transplantation for infantile osteopetrosisPaul J Orchard, Anders L Fasth, Jennifer Le Rademacher, et al.
Pageof 84